The potential impact of bisphosphonates on major adverse cardiovascular events: a study of 1,097,406 patients
Event:
ESC Congress 2024
Topic:
Epidemiology, Prognosis, Outcome
Session:
Integrating insights: from biomarkers to therapeutics in the management of acute coronary syndromes
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
